Suppr超能文献

羟色氨酸添加到单胺氧化酶抑制剂后出现躁狂。

Mania following addition of hydroxytryptophan to monoamine oxidase inhibitor.

机构信息

Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA.

出版信息

Gen Hosp Psychiatry. 2012 Jan-Feb;34(1):102.e13-4. doi: 10.1016/j.genhosppsych.2011.08.014. Epub 2011 Oct 2.

Abstract

This case report highlights the risk of nutritional supplements and misinformation obtained from the internet particularly for those on monamine oxdiase inhibitors (MAOIs). Despite sophisticated medical knowledge, this patient, who was taking an MOAI and complying with a tyramine-free diet, used a supplement of hydroxytryptophan that along with the MAOI appears to have precipitated mania, despite no personal or familial history of bipolar disorder.

摘要

本病例报告强调了营养补充剂和互联网上错误信息的风险,特别是对于那些正在服用单胺氧化酶抑制剂(MAOIs)的人。尽管这位患者具有复杂的医学知识,并且正在服用 MAOI 并遵循不含酪胺的饮食,但他使用了羟色氨酸补充剂,这种补充剂与 MAOI 一起似乎引发了躁狂,尽管他没有个人或家族的双相情感障碍病史。

相似文献

1
Mania following addition of hydroxytryptophan to monoamine oxidase inhibitor.羟色氨酸添加到单胺氧化酶抑制剂后出现躁狂。
Gen Hosp Psychiatry. 2012 Jan-Feb;34(1):102.e13-4. doi: 10.1016/j.genhosppsych.2011.08.014. Epub 2011 Oct 2.

引用本文的文献

本文引用的文献

5
MAOIs in the contemporary treatment of depression.单胺氧化酶抑制剂在当代抑郁症治疗中的应用
Neuropsychopharmacology. 1995 May;12(3):185-219. doi: 10.1016/0893-133X(94)00058-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验